Fatemeh Molaabasi

Dr. Fatemeh Molaabasi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2021 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
ZGZahra Gharehdaghi
Zahra Gharehdaghi
RRRahmatollah Rahimi
Rahmatollah Rahimi
SNSeyed Morteza Naghib
Seyed Morteza Naghib
FMFatemeh Molaabasi
Fatemeh Molaabasi

13 July 2018 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
MSMojtaba Shamsipur
Mojtaba Shamsipur
FMFatemeh Molaabasi
Fatemeh Molaabasi
MSMorteza Sarparast
Morteza Sarparast
ERElahe Roshani
Elahe Roshani
ZVZahra Vaezi
Zahra Vaezi
SHSaman Hosseinkhani
Saman Hosseinkhani

5 January 2022 in Journal of the Iranian Chemical Society
Verified
Journal Article
Closed access
PDF file
ZGZahra Gharehdaghi
Zahra Gharehdaghi
RRRahmatollah Rahimi
Rahmatollah Rahimi
SNSeyed Morteza Naghib
Seyed Morteza Naghib
FMFatemeh Molaabasi
Fatemeh Molaabasi

4 April 2023 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
ZGZahra Gharehdaghi
Zahra Gharehdaghi
SNSeyed Morteza Naghib
Seyed Morteza Naghib
RRRahmatollah Rahimi
Rahmatollah Rahimi
ABAtin Bakhshi
Atin Bakhshi
AKAmirhosein Kefayat
Amirhosein Kefayat
FMFatemeh Molaabasi
Fatemeh Molaabasi
Cu-BTC framework has received a considerable attention in recent years as a drug carrier candidate for cancer treatment due to its unique structural properties and promising biocompatibility. However, its intrinsic deficiency for medical imaging potentially limits its bioapplications; To address this subject, a magnetic nano/microscale MOF has been successfully fabricated by introducing Fe3O4 nanoparticles as an imaging agent into the porous isoreticular MOF [Cu3(BTC)2] as a drug carrier. The synthesized magnetic MOFs exhibits a high loading capacity (40.5%) toward the model anticancer DOX with an excellent pH-responsive drug release. The proposed nanocomposite not only possesses large surface area, high magnetic response, large mesopore volume, high transverse relaxivity (r2) and good stability but also exhibits superior biocompatibility, specific tumor cellular uptake, and significant cancer cell viability inhibitory effect without any targeting agent. It is expected that the synthesized magnetic nano/microcomposite may be used for clinical purposes and can also serve as a platform for photoactive antibacterial therapy ae well as pH/GSH/photo-triple-responsive nanocarrier.

28 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FMFatemeh Molaabasi
Fatemeh Molaabasi
MSMorteza Sarparast
Morteza Sarparast
MSMojtaba Shamsipur
Mojtaba Shamsipur
LILeila Irannejad
Leila Irannejad
AMAli Akbar Moosavi-Movahedi
Ali Akbar Moosavi-Movahedi
RGReza Ghazfar
Reza Ghazfar
Engineering hollow and porous platinum nanostructures using biomolecular templates is currently a significant focus for the enhancement of their facet-dependent optical, electronic, and electrocatalytic properties. However, remains a formidable challenge due to lack of appropriate biomolecules to have a structure-function relationship with nanocrystal facet development. Herein, human hemoglobin found to have facet-binding abilities that can control the morphology and optical properties of the platinum nanoclusters (Pt NCs) by regulation of the growth kinetics in alkaline media. Observations revealed the growth of unusual polyhedra by shape-directed nanocluster attachment along a certain orientation accompanied by Ostwald ripening and, in turn, yield well-dispersed hollow single-crystal nanotetrahedrons, which can easily self-aggregated and crystallized into porous and polycrystalline microspheres. The spontaneous, biobased organization of Pt NCs allow the intrinsic aggregation-induced emission (AIE) features in terms of the platinophilic interactions between Pt(II)-Hb complexes on the Pt(0) cores, thereby controlling the degree of aggregation and the luminescent intensity of Pt(0)@Pt(II)−Hb core−shell NCs. The Hb-Pt NCs exhibited high-performance electrocatalytic oxygen reduction providing a fundamental basis for outstanding catalytic enhancement of Hb-Pt catalysts based on morphology dependent and active site concentration for the four-electron reduction of oxygen. The as-prepared Hb-Pt NCs also exhibited high potential to use in cellular labeling and imaging thanks to the excellent photostability, chemical stability, and low cytotoxicity.

11 December 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AZAli-Akbar Zare
Ali-Akbar Zare
HNHossein Naderi-Manesh
Hossein Naderi-Manesh
SNSeyed Morteza Naghib
Seyed Morteza Naghib
MSMojtaba Shamsipur
Mojtaba Shamsipur
FMFatemeh Molaabasi
Fatemeh Molaabasi
Breast cancer detection at an early stage significantly increases the chances of successful treatment and survival. This study presents an electrochemical biosensor for detecting breast cancer cells, utilizing silver nanoclusters encapsulated by hemoglobin and Cu (II)-porphyrin-metal organic framework (BioMOF) in a graphene-incorporated nanohybrid probe. This Hb-AgNCs@MOF-G probe demonstrates high electrochemical activity, superior dispersity, porosity, and a large surface area for effective functionalization. Using a green ultrasonic-assisted stirring method, we fabricate ultra-small 5 nm particles that readily immobilize on a glassy carbon electrode, generating a detection signal when interacting with ferricyanide/ferrocyanide redox probes. The resulting immunosensor detects as few as 2 cells/mL using Electrochemical Impedance Spectroscopy (EIS) “signal on” and 16 cells/mL via Square Wave Voltammetry (SWV) “signal off”, within a broad range of cell concentrations (102–5 × 104 cells/mL). Our designed sensor shows improved selectivity (5- to 16-fold) and robust detection in human blood with a recovery efficiency between 94.8–106% (EIS method) and 95.4–111% (SWV method). This sensor could streamline early cancer diagnosis and monitor patient treatment without requiring labelling or signal amplification. As a pioneering endeavor, we've utilized integrated porous MOFs with Hb-encapsulated silver nanoclusters in cancer detection, where these components collectively enhance the overall functionality.